AU5310898A - Release-controlled coated tablets - Google Patents
Release-controlled coated tabletsInfo
- Publication number
- AU5310898A AU5310898A AU53108/98A AU5310898A AU5310898A AU 5310898 A AU5310898 A AU 5310898A AU 53108/98 A AU53108/98 A AU 53108/98A AU 5310898 A AU5310898 A AU 5310898A AU 5310898 A AU5310898 A AU 5310898A
- Authority
- AU
- Australia
- Prior art keywords
- release
- coated tablets
- controlled coated
- controlled
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK1456/96 | 1996-12-20 | ||
DK145696 | 1996-12-20 | ||
PCT/DK1997/000582 WO1998027967A1 (en) | 1996-12-20 | 1997-12-18 | Release-controlled coated tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5310898A true AU5310898A (en) | 1998-07-17 |
Family
ID=8105028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53108/98A Abandoned AU5310898A (en) | 1996-12-20 | 1997-12-18 | Release-controlled coated tablets |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5310898A (en) |
WO (1) | WO1998027967A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
KR20010069756A (en) * | 2001-05-08 | 2001-07-25 | 유형선 | Method for controlled release of acemetacin in the intestinal tract and more particularly in the colon |
DK1453487T3 (en) * | 2001-11-23 | 2008-07-21 | Procter & Gamble | Multiple coatings pharmaceutical dosage form for reduced coating breakage effect |
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
NZ535455A (en) | 2002-02-21 | 2009-08-28 | Biovail Lab Int Srl | Controlled release dosage forms |
US20040029959A1 (en) * | 2002-08-08 | 2004-02-12 | John Devane | Isosorbide mononitrate compositions and methods of their use |
US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
AU2006253007B2 (en) | 2005-05-31 | 2012-12-20 | Alimentary Health Ltd | Feline probiotic Bifidobacteria |
EP2261323A1 (en) | 2005-05-31 | 2010-12-15 | The Iams Company | Feline probiotic lactobacilli |
CA2673465A1 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
WO2010026993A1 (en) | 2008-09-03 | 2010-03-11 | 武田薬品工業株式会社 | Method for improving absorbability of preparation, and preparation having improved absorbability |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
GR1007237B (en) * | 2009-12-07 | 2011-04-08 | Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, | New process for the production of a stable pharmaceutical composition of intestine-soluble acetylsalicylic acid tablets coated with gastro-resistant film |
KR101820181B1 (en) | 2010-04-30 | 2018-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | Enteric tablet |
KR20130060220A (en) | 2010-04-30 | 2013-06-07 | 다케다 야쿠힌 고교 가부시키가이샤 | Enteric tablet |
JP6121990B2 (en) | 2011-05-13 | 2017-04-26 | イービー アイピー ハイブリタブス ビー.ブイ. | Drug delivery system |
JP2012107058A (en) * | 2012-02-27 | 2012-06-07 | Warner Chilcott Co Llc | Pharmaceutical dosage form with multiple coatings |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2471186A1 (en) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS |
DE3403329A1 (en) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | PHARMACEUTICAL PRODUCT IN THE FORM OF PELLETS WITH CONTINUOUS, DELAYED DELIVERY OF ACTIVE SUBSTANCES |
SE460945B (en) * | 1987-01-15 | 1989-12-11 | Lejus Medical Ab | A MULTIPLE-UNIT DOS COMPOSITION OF FUROSEMID |
IT1246382B (en) * | 1990-04-17 | 1994-11-18 | Eurand Int | METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON |
DE4313726A1 (en) * | 1993-04-27 | 1994-11-03 | Byk Nederland Bv | Solid dosage form |
WO1996026722A1 (en) * | 1995-02-28 | 1996-09-06 | Astra Aktiebolag | Use of isosorbide-5-mononitrate |
-
1997
- 1997-12-18 AU AU53108/98A patent/AU5310898A/en not_active Abandoned
- 1997-12-18 WO PCT/DK1997/000582 patent/WO1998027967A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998027967A1 (en) | 1998-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5310898A (en) | Release-controlled coated tablets | |
AU5443698A (en) | Coated detergent tablet | |
AU5259398A (en) | Hopper | |
AU5235796A (en) | o-hydroxyphenyl-s-triazines | |
AU4780896A (en) | Core-board | |
AU1030997A (en) | Taphane | |
AU5443898A (en) | Coated detergent tablet | |
AU7625098A (en) | Coated detergent tablet | |
AU4996696A (en) | 2-benzyl-3-arylbenzothiophenes | |
AU5147496A (en) | Fucopeptides | |
AU7638596A (en) | Rotary sprinkler | |
AU5593896A (en) | Benzisothiazolyl-substituted aminomethylchromans | |
AU5500196A (en) | Anti-transpirants | |
AU4382896A (en) | Acetylimidazobenzodiazepines | |
AU1834097A (en) | Shared counter | |
AU5108596A (en) | Morphine-3-esters | |
AU687716B3 (en) | Sprinkler | |
AU5013796A (en) | Wireclamp | |
AU5107096A (en) | Haemodialyser | |
AU4391997A (en) | Tablet dispenser | |
AU2308097A (en) | Rapid-release s1452 tablets | |
AU4569496A (en) | Tetralinyl- and indanyl-ethylamides | |
AUPO433396A0 (en) | Sprinkler | |
AU4831396A (en) | Pyrazolotetracyclines | |
AU2012697A (en) | Bottle-opener |